Columnist · Editorial Staff

Penelope Marsh

Reports on safety, side effects, and informed consent in plastic surgery.

10 dispatches by Penelope Marsh

Industry · July 6, 2026

Breast Imaging After Implants and Fat Transfer: Why It Stopped Being the Complication It Once Was

A generation ago, cosmetic breast surgery was treated as something that quietly compromised your future mammograms. Implants hid tissue. Fat transfer scattered calcifications that looked like trouble. The worry was real enough that the profession once discouraged fat grafting to the breast on imaging grounds alone. That era is over. Breast imaging after implants and fat transfer is now a well-mapped problem with standard techniques and clear guidance, provided the patient does one thing: tell the imaging center what was done, and to whom.

Industry · June 10, 2026

Why Some Fat Grafts Survive and Others Disappear: The Biology of Fat Graft Survival

Fat grafting sounds simple: take fat from one place, put it somewhere it is wanted, and let it stay. The reality is that a meaningful fraction of every graft dies, and the percentage that survives varies from roughly thirty to seventy depending on factors the surgeon controls and factors the tissue dictates. The honest read is that fat graft survival is a biology problem before it is a technique problem, and the practices that get durable results are the ones that respect what the tissue needs to live.

Industry · June 5, 2026

Awake Liposuction: Where the Evidence Has Landed

Awake liposuction, performed under local tumescent anesthesia instead of general anesthesia, has moved from a niche dermatology technique to a mainstream option marketed by clinics on speed and low downtime. The safety record is genuinely strong when the technique stays inside its limits. The honest read is that awake protocols solved a real problem with general anesthesia, but the marketing has stretched the procedure past the volume and the body areas it was designed for.

Procedure Deep-Dive · June 4, 2026

Sculptra and the Collagen Timeline: Why the Best Results Take Months to Show Up

Sculptra is sold in the same waiting room as filler, but it does not behave like filler, and the difference is almost entirely a matter of time. The product that looks like a letdown at two weeks is often the one doing the most durable work. Here is what poly-L-lactic acid actually does inside the skin, why the honest timeline is measured in months, and how to tell a clinic that explains this from one that hopes you will not ask.

Procedure Deep-Dive · June 1, 2026

Fat Transfer to the Face: What It Fixes That Filler Cannot, and What It Will Not

Fat transfer to the face is sold as the natural alternative to filler, your own tissue instead of a syringe of gel. That part is true. What gets left out is that a meaningful share of the fat never survives, and the result depends on a surgeon you cannot evaluate from a price quote.

Industry · May 28, 2026

The Deep-Plane Facelift's Decade: How a Specialist Technique Became the Standard

In 2015 the deep-plane facelift was a procedure a small number of surgeons performed and the rest of the field watched. By 2025 it had become the operation patients walk in asking for by name, and the question is no longer whether to do it but what it actually changes about how a face ages.

Procedure Deep-Dive · May 27, 2026

Filler for Hollow Temples: One of the Earliest Signs of Facial Aging, and One of the Trickiest Places to Inject

Filler for hollow temples treats a sign of facial aging most people notice long before they can name it. It is also one of the more anatomically dangerous injections on the face. Here is what temple volume loss actually does, why the region demands a specific kind of caution, and the question that separates a careful injector from a confident one.

Industry · May 27, 2026

Stem Cell Claims in Aesthetic Surgery: What the FDA Actually Allows

A stem cell facelift sounds like next-generation medicine. In most clinics it is fat grafting with a better name, and the part the marketing leaves out is that the FDA has not approved a single stem cell product for cosmetic use.

Procedure Deep-Dive · May 21, 2026

Collagen Banking in Your 30s: What the Science Supports and What the Marketing Oversells

Collagen banking has become the dominant framing for preventative aesthetics. The biology is real. The savings-account metaphor does a lot of work. Here is what the evidence supports for starting in your 30s, and where the marketing has run ahead of it.

Procedure Deep-Dive · May 20, 2026

The Quiet Maturation of Fat Transfer Breast Augmentation

A decade ago, fat transfer to the breast was the experimental option. Today it is the considered alternative for a defined class of patients. The data has caught up to the technique, and so has the consultation.

All dispatches